These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18079669)

  • 1. [Molecular pharmacogenetics in hospital laboratories in France: current data and future prospects].
    Allorge D; Beaune PH; Becquemont L; Bessard G; Bezieau S; Boisdron-Celle M; Boyer JC; Broly F; Dhaneens CM; Fonrose X; Gagnieu MC; Gamelin E; Gozé C; Jacqz-Aigrain E; Loric S; Loriot MA; Marquet P; Morel A; Namour B; Paintaud G; Peoc'h K; Picard N; Watier H; Verstuyft C
    Ann Pharm Fr; 2007 Nov; 65(6):371-81. PubMed ID: 18079669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience.
    van Aken J; Schmedders M; Feuerstein G; Kollek R
    Am J Pharmacogenomics; 2003; 3(3):149-55. PubMed ID: 12814323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
    Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
    Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetic screening and therapeutic drugs.
    Steimer W; Potter JM
    Clin Chim Acta; 2002 Jan; 315(1-2):137-55. PubMed ID: 11728416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic testing in the United Kingdom genetics and immunogenetics laboratories.
    Higgs J; Gambhir N; Ramsden SC; Poulton K; Newman WG
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):121-5. PubMed ID: 20039783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy.
    Albertini L; Siest G; Jeannesson E; Visvikis-Siest S
    Pharmacogenomics; 2011 May; 12(5):681-91. PubMed ID: 21619430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Medicine in the Paediatric Population: The Balance Between Pharmacogenetic Progress and Bioethics.
    Schiavone S; Neri M; Pomara C; Riezzo I; Trabace L; Turillazzi E
    Curr Pharm Biotechnol; 2017; 18(3):253-262. PubMed ID: 28176639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacogenetics for patient care in France: A discipline that evolves!].
    Barin-Le Guellec C; Picard N; Alarcan H; Barreau M; Becquemont L; Quaranta S; Boyer JC; Loriot MA;
    Therapie; 2020; 75(5):459-470. PubMed ID: 31767126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics in biological perspective.
    Kalow W
    Pharmacol Rev; 1997 Dec; 49(4):369-79. PubMed ID: 9443163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of DNA tests from research to routine laboratories: some lessons from the French experience in the case of Duchenne muscular dystrophy.
    Hirtzlin I
    Health Policy; 1996 Jan; 35(1):1-11. PubMed ID: 10172594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prometheus Laboratories Inc. obtains license to patent for pharmacogenetic test.
    Expert Rev Mol Diagn; 2002 Nov; 2(6):525. PubMed ID: 12465443
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenetics and nicotine addiction treatment.
    Munafò MR; Shields AE; Berrettini WH; Patterson F; Lerman C
    Pharmacogenomics; 2005 Apr; 6(3):211-23. PubMed ID: 16013953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoiding adverse drug reactions by pharmacogenetic testing: a systematic review of the economic evidence in the case of TPMT and AZA-induced side effects.
    Compagni A; Bartoli S; Buehrlen B; Fattore G; Ibarreta D; de Mesa EG
    Int J Technol Assess Health Care; 2008; 24(3):294-302. PubMed ID: 18601797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics approach to therapeutics.
    Koo SH; Lee EJ
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):525-32. PubMed ID: 16700889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and the future of medical practice.
    Lindpaintner K
    Br J Clin Pharmacol; 2002 Aug; 54(2):221-30. PubMed ID: 12207645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenetics or the promise of a personalized medicine: variability in drug metabolism and transport].
    Allorge D; Loriot MA
    Ann Biol Clin (Paris); 2004; 62(5):499-511. PubMed ID: 15355800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics in clinical dermatology.
    Ameen M; Smith CH; Barker JN
    Br J Dermatol; 2002 Jan; 146(1):2-6. PubMed ID: 11841360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The drugs don't work: pharmacogenomics--clinical biochemistry's future?
    Hallworth MJ
    Ann Clin Biochem; 2004 Jul; 41(Pt 4):260-2. PubMed ID: 15298737
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenetics of anti-cancer drugs: State of the art and implementation - recommendations of the French National Network of Pharmacogenetics.
    Quaranta S; Thomas F
    Therapie; 2017 Apr; 72(2):205-215. PubMed ID: 28262261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.